Hvsen Biotechnology Co., Ltd.
SZSE:300871.SZ
14.16 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| 16.781 | 52.706 | 132.866 | 150.156 | 68.766 | 71.402 | 88.409 | 49.398 |
| Depreciation & Amortization
| 120.389 | 62.571 | 28.54 | 19.082 | 12.546 | 12.024 | 9.766 | 7.12 |
| Deferred Income Tax
| -10.299 | -4.919 | -2.208 | 0.897 | -6.127 | -2.066 | 0.211 | 0.31 |
| Stock Based Compensation
| 0 | -0.764 | 0.764 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -76.196 | -31.101 | -18.898 | -130.34 | -2.309 | -77.648 | -20.341 | 0.739 |
| Accounts Receivables
| -109.82 | 14.44 | 21.694 | -195.019 | -37.198 | -45.666 | -31.79 | -2.844 |
| Inventory
| -28.059 | 30.42 | -105.917 | -55.823 | 8.85 | -24.828 | -10.044 | -23.533 |
| Accounts Payables
| 71.981 | -71.043 | 67.533 | 119.606 | 32.167 | -5.091 | 21.263 | 26.788 |
| Other Working Capital
| 0 | -4.919 | -2.208 | 0.897 | -6.127 | -52.82 | -10.297 | 24.272 |
| Other Non Cash Items
| 28.848 | 12.504 | 13.211 | 9.45 | 26.238 | 15.318 | 2.724 | 2.747 |
| Operating Cash Flow
| 92.919 | 96.68 | 155.718 | 48.349 | 105.241 | 21.096 | 80.559 | 60.004 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -184.312 | -428.865 | -600.123 | -230.844 | -123.059 | -34.054 | -56.4 | -27.97 |
| Acquisitions Net
| 0 | 0.074 | 600.225 | 231.033 | 0.114 | 0.038 | 0.236 | 0.029 |
| Purchases Of Investments
| -985.526 | -1,020 | -210 | -500 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 1,069.534 | 699.25 | 624.875 | 60.215 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 84.008 | 0 | -600.123 | -230.844 | 0 | 0.038 | 0.236 | 0.053 |
| Investing Cash Flow
| -100.304 | -749.542 | -185.145 | -670.44 | -122.945 | -34.016 | -56.164 | -27.916 |
| Financing Activities: | ||||||||
| Debt Repayment
| -33.451 | -135.209 | -61.692 | -119.9 | -36.1 | -28 | -13.5 | -11.5 |
| Common Stock Issued
| 0 | 53.677 | -4.628 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| -3.31 | -53.677 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -48.969 | -54.91 | -45.308 | -5.993 | -15 | -21.63 | -24.378 | -19.771 |
| Other Financing Activities
| 50.608 | 163.091 | 696.331 | 951.617 | 74.69 | 103 | 13.458 | 18.09 |
| Financing Cash Flow
| -41.476 | -34.603 | 710.088 | 825.725 | 21.884 | 53.37 | -24.42 | -13.181 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| -0.233 | -0.07 | -0.027 | -0.037 | 0.005 | 0.049 | -0.001 | 0.013 |
| Net Change In Cash
| -49.094 | -687.534 | 680.633 | 203.597 | 4.185 | 40.498 | -0.026 | 18.92 |
| Cash At End Of Period
| 229.512 | 278.606 | 966.141 | 285.507 | 81.91 | 77.725 | 37.227 | 37.253 |